Collaborations

Our company's substantial experience in every type of partnership, includes: contract manufacturing, third party services, licensing-in, co-marketing, co-promotion and distribution. ELPEN's group of companies enjoy the reputation of being the partner of choice for the Greek market, the testimonial of which is shown here below:

International Partnerships & Collaborations


COLLABORATION  TYPE  COMPANY                            

TIME PERIOD
PRODUCT (API)
Contract Manufacturing Eaton, USA 1975-1981
Dow Chemicals, USA 1976-1990
Pierre Fabre, Fr 1977-1990
Warner Lambert, USA 1977-1992
Third Party Services Aceto, Ger 2000-present
Arrow, Ir 2003-present
Pharmacare, It 2004-present
Distribution Baxter, USA 2002-2004 GentaFleece®
(gentamycin implant)
2009-present Brevibloc®(esmolol)
Licensing-in Italfarmaco, It 1991-present Legofer®
(iron protein succinylate)
Euritalia, It 2005-2008 Isomar®
(isotonic sea water)
Hospira, USA 2006-present Retacrit® (epoetin-z)
2011-present Nivetsim® (filgrastim)
Co-marketing Bayer, Ger 1999-2001 Eltina® (cerivastatin)
2001-present Octegra® (moxifloxacin)
2010-present Zevalin®
(ibritumomab tiuxetan)
Lundbeck, Den 2005-present Entact® (escitalopram)
Novartis, Switz 2007-present Dalzad® / CoDalzad® (valsartan +HCTZ)
2007-present Copalia®
(amlodipine + valsartan)
2009-present Zomarist®
(vildagliptin + metformin)
2009-present Jalra® (vildagliptin)
Pfizer, USA 2009-present Zarator® (atorvastatin)
Recordati, It 2009-present Zaneril®
(lercanidipine + enalapril)
Menarini, It 2011-present Hypoloc® (nebivolol)
2011-present Hypoloc® plus
(nebivolol+HCTZ)
Co-promotion Genzyme, USA 2009-present Cholestagel® (colesevelam)
Co-promotion/
Distribution
Ferring, Switz 2012-present Glypressin® (terlipressin)
Tractocile® (atosiban)
Zomacton® (somatropin)


It is an acknowledged fact, in Greece as well as in the international pharmaceutical community, that ELPEN offers a vast experience in all types of collaborations, applying superior professionalism and know-how to successfully undergo the necessary aspects required for the dynamic introduction and promotion of pharmaceuticals in Greece.

Home |Sitemap|Career|Legal Notice|Experimental & Research |Contact
2009-2012 ELPEN | created by PharmaComm, all rights reserved.